NBS >>> NeoStem, Inc. Announces the Redemption of the Outstanding 7% Series E Preferred Stock
2012-10-17 07:30 ET - News Release
NEW YORK, Oct. 17, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy market, today announced that it will redeem all outstanding shares of its Series E 7% Senior Convertible Preferred Stock ("Series E Preferred Stock").
On October 10, 2012, the Company gave notice to its Series E Preferred Stockholders that it is redeeming all of the outstanding shares of Series E Preferred Stock for an aggregate redemption price of $3.4 million, $2.5 million of which was funded by money placed into escrow when the Series E Preferred stock was issued in November 2010.
"We are pleased that we have been able to redeem this $10 million investment in full over a two year period. Equal to our focus on cell therapy product development and expanding our PCT contract development and manufacturing operations, we are committed to improving our balance sheet. Through the redemption of the Series E Preferred Stock, we will remove a significant overhang and simplify NeoStem's capital structure. The redemption of the Series E Preferred Stock is another example of a step taken by us to improve Common Stockholder value," said Dr. Robin Smith, Chairman and CEO of NeoStem. "We look forward to continued execution on our near term business strategy, including the forthcoming closing of the divestiture of our Erye China pharmaceutical subsidiary."
About NeoStem, Inc.
NeoStem, Inc. continues to develop and build on its core capabilities in cell therapy, capitalizing on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a significant role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. We are emerging as a technology and market leading company in this fast developing cell therapy market. Our multi-faceted business strategy combines a state-of-the-art contract development and manufacturing subsidiary, Progenitor Cell Therapy, LLC ("PCT"), with a medically important cell therapy product development program, enabling near and long-term revenue growth opportunities. We believe this expertise and existing research capabilities and collaborations will enable us to achieve our mission of becoming a premier cell therapy company.
Our contract development and manufacturing service business supports the development of proprietary cell therapy products. NeoStem's most clinically advanced therapeutic, AMR-001, is being developed at Amorcyte, LLC ("Amorcyte"), which we acquired in October 2011. Amorcyte is developing a cell therapy for the treatment of cardiovascular disease and is enrolling patients in a Phase 2 trial to investigate AMR-001's efficacy in preserving heart function after a heart attack. Athelos Corporation ("Athelos"), which is approximately 80%-owned by our subsidiary, PCT, is collaborating with Becton-Dickinson in the early clinical exploration of a T-cell therapy for autoimmune conditions. In addition, pre-clinical assets include our VSELTM Technology platform as well as our mesenchymal stem cell product candidate for regenerative medicine. Our service business and pipeline of proprietary cell therapy products work in concert, giving us a competitive advantage that we believe is unique to the biotechnology and pharmaceutical industries. Supported by an experienced scientific and business management team and a substantial intellectual property estate, we believe we are well positioned to succeed.
For more information on NeoStem, please visit www.neostem.com.
Forward-Looking Statements for NeoStem, Inc.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy, including with respect to the Company's or its partners' successful development of AMR-001 and other cell therapeutics, the size of the market for such products, its competitive position in such markets, the Company's ability to successfully penetrate such markets and the market for its contract development and manufacturing ("CDMO") business, and the efficacy of protection from its patent portfolio, as well as the future of the cell therapeutics industry in general, including the rate at which such industry may grow. Forward looking statements also include statements with respect to satisfying all conditions to closing the disposition of Erye, including receipt of all necessary regulatory approvals in the PRC. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors, including but not limited to matters described under the "Risk Factors" in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 20, 2012 and in the Company's other periodic filings with the Securities and Exchange Commission, all of which are available on its website. The Company does not undertake to update its forward-looking statements. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.
CONTACT: Trout Group
Gitanjali Jain Ogawa, Vice President
Phone: +1-646-378-2949
Email: gogawa@troutgroup.com
NBS NeoStem, Inc. Announces the Redemption of the
Top 10 Most Recent News Articles
Data Center Piping Surges With AI Cooling to $4.5B
Liquid Cooling Revolutionizes Data Center Infrastructure Gotta hand it to the tech world, when it decides to shift, it shifts hard and fast. The data center piping market isn't just keeping up—it's sprinting. The move towards liquid-cooled AI setups isn’t just a trend; it’s a defining transformation. With a projected explosion to a $4.5 billion market by 2035, you...
Continue Reading
Millrose Faces Class Action: Blame Game in Motion
Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...
Continue Reading
Third Eye Demands Fairer Terms for SkyAI Buyout
Revamping the SkyAI Tender Offer Third Eye's backing of Bastion Trading's push for better terms in SkyAI's tender offer has put a spotlight on those crafty boardroom maneuvers. Investors aren't exactly thrilled with the crumbs being thrown their way, and it's about time someone held the cooks accountable. Getting What's Owed Here's the gist of it: Third Eye's not asking...
Continue Reading
Axis Fabrication Kicks Off New High-Tech Facility
Axis Fab Unveils a Cutting-edge Hub No shortcuts here, folks. Axis Fabrication & Machine is rolling out the red carpet on November 4, 2026, to flaunt their brand-new 78,000-square-foot manufacturing beast in Rockford, Tennessee. We're talking about a $24 million bet on the future—a clear signal Axis is doubling down on the surge of industrial dynamism sweeping East...
Continue Reading
Tide Rock Snags Electro-Spec: Big Moves in Industrial Plating
Tide Rock Dives Deeper into Surface Finishing Here's the scoop: Tide Rock is getting serious about its ambitions in the specialty manufacturing scene, having scooped up Electro-Spec, one helluva player in the plating and surface finishing domain. This acquisition isn't just another notch in Tide Rock’s belt—it's a calculated move to fortify their position in a game...
Continue Reading
ServiceTitan Faces Investigation: Stock Tanks 30%
ServiceTitan Lands in Hot Water Here we go again. News rolled in on September 8, 2026, catching investors like a deer in headlights. ServiceTitan, the operating systems provider that’s been riding the waves of the building and trades industries, just got clobbered with an investigation. As if grappling with their Max AI rollout wasn't enough, Robbins Geller Rudman &...
Continue Reading
Verda & Compal Expand AI Infrastructure Globally
AI Infrastructure Takes Center Stage Grab your coffee because Verda and Compal are shaking up the AI scene with their latest announcement from GTC Berlin 2026. The duo's expanding their collaboration, and if you're watching the markets, this isn't something you can ignore. With Verda's AI cloud muscle and Compal's beefed-up global manufacturing, we're talking about a...
Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients
Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...
Continue Reading
ASUS Unveils NVIDIA HGX AI Systems at GTC Berlin
A Shake-Up in AI Infrastructure: ASUS Steps In Who's ready for a seismic shift in AI tech? ASUS popped out the gate with a big reveal at the NVIDIA GTC Berlin 2026, showcasing its new arsenal of AI systems built on NVIDIA's HGX Rubin NVL8. These aren't your average rigs either; they're set to hit the market in Q4 2026 with configurations that cater to everything from AI...
Continue Reading
ASEAN University Rankings: Singapore and Malaysia Shine
Singapore and Malaysia Dominate the Rankings You ever notice how all these rankings come out, and it's the same names topping the list? Well, in the latest AppliedEdu University Rankings 2027 for ASEAN, it's business as usual with the National University of Singapore (NUS) and Sunway University taking the cake yet again. That's three and four years consecutively,...
Continue ReadingTop 5 Most Recently Viewed Articles
Discover the Sleek and Stylish 2025 Toyota Corolla Today
Explore the New 2025 Toyota Corolla For those in search of a stylish, fuel-efficient, and tech-savvy sedan, the 2025 Toyota Corolla has arrived and is ready to impress. This compact car is now available for drivers who desire a perfect blend of sophistication and practicality. Unveiling the Corolla's Features The 2025 Toyota Corolla combines sleek design with innovative...
Continue Reading
Royal Unibrew Reports on 2024 Performance and Future Plans
Royal Unibrew's Annual Report Review for 2024 In a detailed announcement regarding Royal Unibrew's Annual Report for the year 2024, the company has presented a comprehensive view of its operations, performance metrics, and strategic direction. The report is not just a formality; it provides stakeholders significant insights into how the company navigated the challenges of...
Continue Reading
Mullen Group Ltd. Declares Exciting Monthly Dividend Growth
Mullen Group Ltd. Declares Exciting Monthly Dividend Growth The Board of Directors at Mullen Group Ltd. recently made a notable announcement regarding their commitment to returning value to shareholders. This Canadian transport and logistics leader has declared a monthly dividend of $0.07 per Common Share. This decision showcases the corporation's robust financial...
Continue Reading
Avacta's AVA6000 Trials Show Exciting Results and Potential
Avacta Unveils Encouraging Data for AVA6000 Trials Avacta Therapeutics is making strides in the field of oncology with its innovative approach to cancer treatment through peptide drug conjugates (PDC). The company has reported promising early efficacy and safety data from its lead program, AVA6000, which employs the cutting-edge pre|CISION® technology. AVA6000, a...
Continue Reading
SOS Inventory Updates Its Brand and Launches New Website
SOS Inventory Unveils Comprehensive Rebrand SOS Inventory, recognized as a leading companion for QuickBooks in inventory management, has recently undergone a dynamic rebranding that reflects its ongoing commitment to providing exceptional inventory solutions to businesses everywhere. The transformation includes a newly designed website that enhances user experience and...
Continue Reading